dasatinib zentiva 20 mg tabletki powlekane
zentiva, k.s. - dasatinibum - tabletki powlekane - 20 mg
dasatinib zentiva 50 mg tabletki powlekane
zentiva, k.s. - dasatinibum - tabletki powlekane - 50 mg
dasatinib zentiva 80 mg tabletki powlekane
zentiva, k.s. - dasatinibum - tabletki powlekane - 80 mg
dasatinib zentiva 100 mg tabletki powlekane
zentiva, k.s. - dasatinibum - tabletki powlekane - 100 mg
dasatinib zentiva 140 mg tabletki powlekane
zentiva, k.s. - dasatinibum - tabletki powlekane - 140 mg
zynrelef
heron therapeutics, b.v. - bupivacaine, meloxicam - ból, pooperacyjny - Środki znieczulające - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.
phesgo
roche registration gmbh - pertuzumab, trastuzumab - nowotwory piersi - Środki przeciwnowotworowe - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
pankaine spinal heavy 5 mg/ml roztwór do wstrzykiwań
panpharma - bupivacaini hydrochloridum - roztwór do wstrzykiwań - 5 mg/ml
grofibrat s 160 mg tabletki powlekane
gedeon richter polska sp. z o.o. - fenofibratum - tabletki powlekane - 160 mg
grofibrat s 215 mg tabletki powlekane
gedeon richter polska sp. z o.o. - fenofibratum - tabletki powlekane - 215 mg